Navigation Links
PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results
Date:1/31/2011

31, 2011), for Fiscal Year 2011 and for Calendar Year 2011 using recent exchange rates.  For the third quarter, the Company anticipates reporting consolidated service revenue in the range of $307 to $312 million, and diluted earnings per share in the range of $0.29 to $0.31.  For Fiscal Year 2011, consolidated service revenue is expected to be in the range of $1.22 to $1.24 billion (previously issued revenue guidance was $1.25 to $1.27 billion).  GAAP earnings per diluted share for Fiscal Year 2011 are projected to be in the range of $1.17 and $1.23 (previously issued GAAP earnings per diluted share guidance was $1.23 to $1.31), and adjusted earnings per diluted share (excluding the special items recorded in Q2 FY2011) are projected to be in the range of $1.18 and $1.24.  For Calendar Year 2011, consolidated service revenue is expected to be in the range of $1.260 to $1.295 billion, and GAAP earnings per diluted share are expected to be in the range of $1.21 to $1.31.

Certain trended financial information may be found in the Investor Relations section of the Company’s website under the “Additional Financials” section.  

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), the Company uses certain non-GAAP financial measures.  The Company believes that presenting the non-GAAP financial measures contained in this press release assists investors and others in gaining a better understanding of its core operating results and future prospects, especially when comparing such results to previous periods or forecasted guidance, because such measures exclude items that are outside of the Company’s normal operations and/or, in certain cases, are difficult to forecast accurately for future periods.  Management uses non-GAAP financial measures, in addition to the measures prepared in accordance with GAAP, as the basis for measuring the Company
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. PAREXEL Announces Date of Second Quarter Fiscal Year 2011 Earnings Release and Conference Call
2. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
3. PAREXEL Announces Date of First Quarter Fiscal Year 2011 Earnings Release and Conference Call
4. PAREXEL Issues Updated Financial And Operational Information
5. PAREXEL Consulting Releases New Study Data on Drug Development Timelines in Safety First Era
6. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
7. PAREXEL International to Present at Robert Baird 2009 Healthcare Conference
8. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
9. PAREXEL International to Present at the Wachovia Equity Conference
10. PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting
11. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ... today reported results of its Oral Amphotericin B ... reservoirs.  The study, conducted by ImmuneCarta®, the immune ... vitro effectiveness of Oral Amp B in ... in individuals despite intensive treatment with antiretroviral therapy. ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... According to the new ... (Municipal Wastewater Treatment and Industrial Wastewater Treatment), By ... By Configuration (Internal/Submerged and External/Sidestream), and By Region-Trends ... market for membrane bioreactor systems is projected to ... CAGR of 15.28% between 2014 and 2019. ...
(Date:8/16/2014)... NY (PRWEB) August 16, 2014 ... industry provide guidance and advisory services to ... and technical issues. Industry services are highly diverse ... Therefore, industry services range from geological and geophysical ... plans. “Consequently, over the past five years, the ...
Breaking Biology Technology:iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 2Scientific and Economic Consulting in Canada Industry Market Research Report Now Available from IBISWorld 3
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced today ... broadcast live over the Internet on Thursday, July 23, 2009, at ... results will be made available at 7:00 a.m. the morning of ... be accessed via Zimmer,s Investor Relations website at ...
... Pa. and NEWTON, Mass., June 30 Microfluidics, ... (OTC Bulletin Board: MFLU), and Particle Sciences Inc. ... biopharmaceutical companies leverage the most advanced and reliable ... and commercialize Active Pharmaceutical Ingredients (APIs). , ...
... June 30 Hospira, Inc. (NYSE: HSP ... today announced agreements with MedAssets on intravenous (I.V.) solutions ... agreement for infusion devices. The five-year MedAssets agreements are ... and equipment, and July 1, 2009, for infusion devices. ...
Cached Biology Technology:Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement 2
(Date:8/19/2014)... MA -- MIT chemical engineers have devised a new ... are released slowly over a few weeks. When applied ... the body to rapidly form new bone that looks ... type of coated scaffold could offer a dramatic improvement ... involves transplanting bone from another part of the patient,s ...
(Date:8/19/2014)... today,s crocodiles colonised the seas during warm phases and ... Anglo-French study which establishes a link between marine crocodilian ... period of more than 140 million years. , ... Universit de Lyon, France and formerly from the University ... Nature Communications ., Today, crocodiles are ,cold-blooded, animals that ...
(Date:8/19/2014)... A team of UTSA researchers has been awarded a ... Technology and Training (NCPTT), an office of the National ... The grant will fund a one-year study of the ... of historic homes in hot, humid climates. , Radiant ... or attics that reflect heat back, thereby reducing the ...
Breaking Biology News(10 mins):Engineering new bone growth 2Engineering new bone growth 3Evolution of marine crocodilians constrained by ocean temperatures 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3
... Angeles New evidence from the University of Southern California ... that help compile small bits of information in order to ... professor of psychology in the area of brain and cognitive ... Public Library of Science journal, PLoS ONE. It ...
... MA--Boston University School of Medicine (BUSM) will present The Sixth ... 14, 2007 at noon. The annual lecture is in honor ... in BUSMs Pulmonary Center. Kim Hanson, along with her ... the second plane that struck the World Trade Center on ...
... University of Oregon has received a $1.6 million grant ... effects of exposure to precisely engineered nanoparticles that are ... three-year grant from the Keck Foundations medical research program ... Andy Berglund, all UO professors of chemistry; UO biology ...
Cached Biology News:Shape encoding may start in the retina 2Lecture to honor victim of Sept. 11 tragedy 2Keck Foundation funds study of biological interactions with nanomaterials 2
...
... measures NOS activity by monitoring the conversion ... is simple, sensitive, and specific for NOS ... crude and purified enzyme preparations. The kit ... total reactions. Radiolabeled arginine and NADPH are ...
Human TSLP MAb (Clone 258136)...
Human Complement Component C5a MAb (Clone 295003)...
Biology Products: